TARIS Biomedical - Liris' Unit Acquisition

TARIS Biomedical - Liris raised a round of funding on August 15, 2014. Investors include Allergan (acquired by Actavis).

TARIS Biomedical, formerly Certus Biomedical, is a clinical stage specialty pharmaceutical company focused on developing a pipeline of treatments for bladder diseases. Current therapies for these cond…

Articles about TARIS Biomedical - Liris' Unit Acquisition: